The Royal Veterinary College Veterinary Epidemiology, Economics and Public Health Group: is a FAO Reference Centre in Veterinary Epidemiology and is the lead institution in the project, providing skills in epidemiological study design, simulation modelling, KAP studies and animal health economics. Previous and current work includes field epidemiological studies and advice on brucellosis control in Africa and Asia. Since 2002 the group has delivered capacity building for veterinary services of 70+ countries. RVC has primary responsibility for field surveys, epidemiological analysis and animal health economics.
The Interstate School of Veterinary Science and Medicine of Dakar (EISMV): A leading training centre in veterinary science in the region (covering 15 countries). EISMV is the regional hub for the work to be carried out in all countries, with primary responsibility on the longitudinal study of farms and co-responsibility with RVC and LSHTM on the remaining field studies and the control programs. Through its strong links to the 15 countries, impact and local capacity building will be maximized.
London School of Hygiene and Tropical Medicine (LSHTM). A leading school for population research with expertise in study design, conduct, analysis of research into the epidemiology and control of tropical diseases including zoonoses and vaccine preventable diseases. For more than 10 years LSHTM has provided joint postgraduate training with RVC in veterinary epidemiology. LSHTM will be responsible for transactional cost economics, surveillance of non-specific fevers and observational studies on risk of human infection.
The Animal and Plant Health Agency (APHA) is a globally recognised UK centre of technical excellence in the detection and diagnosis of communicable veterinary disease. The laboratories at APHA include many (14) OIE Reference Laboratories, one of them for Brucellosis. The OIE Reference Laboratory for Brucellosis at the APHA (also an FAO/WHO Collaborating Centre for Brucellosis) plays a very important national role in maintaining the brucellosis free status of Great Britain, critically instrumental in achieving the eradication of brucellosis from Great Britain in 1985. It developed, holds and distributes all over the world the OIE International Standard Sera for the standardisation of the OIE prescribed serodiagnostic assays to National Reference Laboratories for Brucellosis and has been at the forefront in the development and validation of serodiagnostic techniques. The brucellosis laboratory at APHA engages in international work, joint research programmes with other OIE laboratories, for example in the development of superior serodiagnostic assays; establishing, and publishing, the first exercise in the harmonisation of serodiagnostic assays for bovine brucellosis across Europe and participates in the OIE Twinning programmes where established laboratories partner with laboratories wishing to become OIE Reference Laboratories. APHA will be responsible for standardization of diagnostics and development of tests appropriate in the study setting–pen-side tests, tests discriminating vaccinated vs. infected animals.
The Global Alliance for Livestock Veterinary Medicines (GALVmed) is a not for profit partnership developing the products and processes to address the critical shortfall in veterinary drugs for the world’s 900 million poor livestock keepers. In the last 5 years GALVmed has been awarded £65.5 million for the delivery of projects in pursuance of this broad mission, which includes product and technology development (e.g. thermostabilised vaccines for Newcastle Disease), field projects and market development (e.g. the distribution and sale of over 500,000 doses of ECF-ITM vaccine doses to poor livestock keepers in East Africa), policy development and product availability (e.g. Establishing the process of mutual recognition for vaccine registration within East African Community member states and organising the first Pan-African meeting of veterinary vaccines regulators as the first steps towards harmonisation of vaccine registration) and capacity building to enhance the long term capacity and efficiency of public institutions in the developing world. Within this project, GALVmed will analyse local vaccine value chains, will contribute to the implementation of the control programs and will build capacity through the vaccine value chain from manufacturers to farmers.